Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
5.74%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 1.79Close
$ 0.39 - $ 1.79 52-Week Range
Ticker Information
Ticker
LCTXCompany Name
LINEAGE CELL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTLINEAGE CELL THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LCTX - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 627K | 5.74% | $ 10.91M |
| 3/31/2025 | $ 598K | 6.26% | $ 9.56M |
| 12/31/2024 | $ 609K | 6.41% | $ 9.5M |
| 9/30/2024 | $ 633K | 7.26% | $ 8.72M |
| 6/30/2024 | $ 668K | 10.8% | $ 6.19M |
| 3/31/2024 | $ 696K | 8.7% | $ 8M |
| 12/31/2023 | $ 692K | 7.74% | $ 8.95M |
| 9/30/2023 | $ 690K | 7.87% | $ 8.77M |
| 6/30/2023 | $ 714K | 6.78% | $ 10.52M |
| 3/31/2023 | $ 720K | 6.07% | $ 11.85M |
Key Performance Insights, Last 5 Years
- LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 94.17%.
- Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average DepAmor % has been 26.53%.
- The median DepAmor % for LINEAGE CELL THERAPEUTICS INC during this period was 7.8%
- LINEAGE CELL THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 115.61%.
- The lowest DepAmor % recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe 4.94%
LINEAGE CELL THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for LINEAGE CELL THERAPEUTICS INC is calculated as follows: DepAmor [ $ 2.55M ] / Revenues [ $ 2.71M ]
(=) DepAmor % [ 94.17% ] LCTX - Depreciation and Amortization Margin, Last 5 years
4.94%
Minimum
Dec 31, 2022
115.61%
Maximum
Dec 31, 2020
26.53%
Average
7.8%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.84% with a standard deviation of 5.11%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.51% |
| average | 5.84% |
| median | 4.21% |
| std | 5.11% |